SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-23-041229
Filing Date
2023-12-11
Accepted
2023-12-11 16:08:28
Documents
1
Period of Report
2023-12-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1702328899.html 4  
1 FORM 4 wk-form4_1702328899.xml 4 3115
  Complete submission text file 0001628280-23-041229.txt   4787
Mailing Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301
Business Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301 (720) 505-4755
Fresh Tracks Therapeutics, Inc. (Issuer) CIK: 0000819050 (see all company filings)

IRS No.: 930948554 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 2000 CENTRAL AVE SUITE 100 BOULDER CO 80301
Business Address
Fox-Collis Aaron (Reporting) CIK: 0001963698 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-21088 | Film No.: 231478203